Post Profile






PierianDx Acquires Tute Genomics

PRESS RELEASE: PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today the acquisition of Tute Genomics, a genomics software company based in Provo, UT. The acquisition furthers PierianDx's goal...
read more

share

Related Posts


Interpreting clinical sequencing results for genome medicine

Academics / General Science : Science Codex

This week, two important papers addressing pressing challenges and the best path forward for interpreting results from clinical genome and exome sequencing will appear in the American Journal of Human Genetics. read more

New Computational Tool For Rapid Identification Of Disease-Causing Variations In The Human Genome

Health : Medical News Today

Scientists from the University of Utah and Omicia, Inc., a privately held company developing tools to interpret personal genome sequences, have announced the publication in Genome Research of a new software tool called VAAST, the Va...

Mayo Clinic and SV Bio Enter Strategic Relationship on Genome Diagnostics and Interpretation

Health : Newswise Medical News

Mayo Clinic and Silicon Valley Biosystems (SV Bio) today announced a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories.

Elsevier Acquires Ariadne Genomics

Technology : SemanticWeb.com

Elsevier has acquired Ariadne Genomics, a company providing pathway analysis tools and semantic technologies to life science researchers. According to Alexander van Boetzelaer of Elsevier, “Ariadne Genomics’ pathway analysis tools a...

Tute Genomics raises $2.3M for genome analytics platform

Technology : Venture Beat

Tute Genomics says it has developed a comprehensive cloud-based genome analytics platform that lets clinicians and researchers identify disease genes and biomarkers in complex genome sequencing data.

Comments


Copyright © 2016 Regator, LLC